DTIL
Precision BioSciences Inc
NASDAQ: DTIL · HEALTHCARE · BIOTECHNOLOGY
$7.15
+3.62% today
Updated 2026-04-30
Market cap
$181.66M
P/E ratio
—
P/S ratio
5.30x
EPS (TTM)
$-3.63
Dividend yield
—
52W range
$4 – $9
Volume
0.3M
Precision BioSciences Inc (DTIL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-133.50%
Operating margin
36.60%
ROE
-62.70%
ROA
-22.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $7.01M | $-8.25M | 100.00% | -125.84% | -117.62% |
| 2017 | $6.48M | $-21.10M | 100.00% | -338.90% | -325.45% |
| 2018 | $10.88M | $-46.04M | 100.00% | -440.25% | -423.02% |
| 2019 | $22.24M | $-92.88M | 100.00% | -392.14% | -417.65% |
| 2020 | $24.29M | $-109.01M | 100.00% | -452.25% | -448.86% |
| 2021 | $115.53M | $-30.60M | 100.00% | -34.08% | -26.49% |
| 2022 | $25.10M | $-111.64M | 100.00% | -248.26% | -444.80% |
| 2023 | $48.73M | $-61.32M | 100.00% | -89.76% | -125.84% |
| 2024 | $68.70M | $7.17M | 100.00% | -38.08% | 10.43% |
| 2025 | $34.26M | $-46.61M | 91.97% | -152.19% | -136.03% |